Intermittent Pneumatic Compression Device (FDA approved)
DeviceCompression Device placed on either upper or lower extremity for DVT prophylaxis following surgery
NCT Number: NCT04341272
Venous thromboembolism (VTE) is an important cause of morbidity and mortality following surgery.A combination of chemical and mechanical prophylaxis using lower extremity compression devices (CD) is recommended in patients who are considered at 'moderate risk' (Caprini score 2 - 4) or 'high risk' (Caprini score > 4) of developing VTE.
The aim of this study was to determine whether upper extremity (UE) CD are as effective as lower extremity (LE) CD in preventing VTE following surgery. A total of 106 patients were recruited.
Looking for future studies?
Notify Me18 year and older
Male
Interventional
Not applicable
Hospitals throughout the United States currently utilize mechanical compression devices on patients' limbs for prevention of blood clots, in addition to blood thinning medication - heparin. The compression devices act by affect blood clotting mechanism and there is evidence from previous research studies that blood is less likely to develop clots when these compression devices are placed on the arms or legs.
The use of compression devices on arms and legs is within standard of care, but use on legs tends to be more common.
Research studies have shown that use of compression devices in combination with heparin is more effective in preventing blood clots than either one alone.
Not many clinicians remember the option of placing compression devices on arms, and patients who do not get compression devices placed on their legs following surgery, often get only medication (heparin) with no compression device placed at all.
This study will compare the effectiveness of compression devices used on patients' arms with those used on patients' legs, at preventing blood clots. Non-invasive ultrasound studies will be used after surgery to check for blood clots in the legs.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Compression Device placed on either upper or lower extremity for DVT prophylaxis following surgery
Time frame: within 45 days following surgery
venous thrombosis (VT) or pulmonary embolism (PE): number of screening lower extremity venous duplex ultrasound studies showing VT and any CT scans showing PE in symptomatic patients
Baltimore VA Medical Center
Fed
Intermittent Pneumatic Compression of the Upper Extremity for Post-Operative VTE Prophylaxis: A Pilot Randomized Trial
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03835780
Arthritis, Arthritis, Psoriatic
London, United Kingdom
View Trial DetailsNCT05794932
Cardiovascular Diseases, Claudication, Intermittent
Montpellier, France
View Trial DetailsNCT04367831
Arterial Thrombosis, COVID-19
New York, United States
View Trial DetailsNCT05087108
Cardiovascular Diseases, Embolism and Thrombosis
Philadelphia, Pennsylvania, United States
View Trial Details